Paying cash from the makers on November 16, 2026, Wegovy is $349 a month at NovoCare (new patients pay $199 for the first two fills at 0.25 mg and 0.5 mg through December 31, 2026), while Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up at LillyDirect. They are different medicines, semaglutide and tirzepatide, and in SURMOUNT-5, the one head-to-head trial, tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent over 72 weeks.
No insurance needed. Two programs to check.
Eden$99 a monthWeight loss warranty includedCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Wegovy comes from Novo Nordisk and Zepbound from Eli Lilly. Both are weekly shots approved for weight loss, and each maker sells its own for cash with a prescription. Which costs less depends on the dose you end up on.
Wegovy vs Zepbound, side by side
| Wegovy | Zepbound |
|---|---|
| Medicine | |
| Semaglutide | Tirzepatide |
| Sold for cash by | |
| NovoCare (Novo Nordisk) | LillyDirect (Eli Lilly) |
| Approved for | |
| Weight loss. Also lowers heart risk in people with heart disease, and treats a fatty liver disease (MASH) | Weight loss in adults with obesity, or with overweight and a weight-related condition. Also moderate to severe obstructive sleep apnea in adults with obesity |
| Cash price | |
| $349 a month for the pen and $399 for the 7.2 mg HD pen | $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up |
| List price before insurance | |
| $1,349.02 a fill | $499 to $1,086.37 a fill |
| Savings card, with commercial insurance | |
| As low as $25/mo (max $100/mo off) | As low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026 |
| Medicare GLP-1 Bridge | |
| $50 a month | $50 a month, Zepbound KwikPen only |
| Doses | |
| 1.7 mg or 2.4 mg, with 2.4 mg marked recommended. Highest dose 7.2 mg weekly | 5 mg, 10 mg or 15 mg. For sleep apnea, 10 mg or 15 mg. Highest dose 15 mg weekly |
Cash prices are NovoCare's and LillyDirect's own, checked November 16, 2026. You need a prescription for either.
Cash price by dose
NovoCare charges $349 a month for the Wegovy pen at every dose from 0.25 mg to 2.4 mg, and $399 for the 7.2 mg HD pen. A new patient pays $199 for each of the first two fills, at 0.25 mg and 0.5 mg, through December 31, 2026.
LillyDirect prices Zepbound by dose, as single-dose vials or the KwikPen: $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. The $449 price needs a refill within 45 days of your last delivery. Without one, 7.5 mg is $499 and 10 mg and up is $699.
So Zepbound's 2.5 mg start is $50 a month below Wegovy's regular pen price, though not below the $199 new-patient fills. From 7.5 mg, Zepbound costs $100 a month more than the Wegovy pen even with the 45-day refill. Every dose: Wegovy cost and Zepbound cost.
Which one took off more weight
SURMOUNT-5 is the one trial that put the two medicines side by side for weight loss. It gave 751 adults with obesity and no type 2 diabetes the highest weekly dose of tirzepatide or semaglutide they could take, for 72 weeks. Tirzepatide, the medicine in Zepbound, took off 20.2 percent of body weight on average. Semaglutide, the medicine in Wegovy, took off 13.7 percent.
Eli Lilly paid for the trial and people knew which drug they were on. The design and its limits: tirzepatide vs semaglutide.
What each is approved for
Wegovy is approved for weight loss. Its label also covers lowering the risk of heart attack and stroke in adults with heart disease, and a fatty liver disease called MASH. Those extra uses are often why a plan or Medicare pays for it.
Zepbound is approved for weight loss and for moderate to severe obstructive sleep apnea in adults with obesity.
Wegovy starts at 0.25 mg, weeks 1 to 4 and steps up to 1.7 mg or 2.4 mg. Zepbound starts at 2.5 mg for 4 weeks and moves to 5 mg after 4 weeks, then 2.5 mg increments after at least 4 weeks on the current dose. The steps by week: Wegovy dosing and Zepbound dosing.
Savings cards with insurance
Each maker's card needs commercial insurance that covers the drug. Wegovy's terms read as low as $25/mo (max $100/mo off). Zepbound's read as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026. Neither works with Medicare, Medicaid or Tricare.
A plan that covers weight loss usually asks for prior approval for either one. Some plans list one brand and not the other, so check your plan's drug list before your prescriber writes it.
Medicare
Medicare's GLP-1 Bridge charges $50 a month for Wegovy and the Zepbound KwikPen to Part D members who qualify, from July 1, 2026 to December 31, 2027. The Zepbound vials do not qualify.
From January 1, 2027, Wegovy also gets a Medicare negotiated price of $274 for a 30-day supply. That is what the plan pays for the drug, not your copay. Tirzepatide is not on that list. More on Medicare's 2027 price for Wegovy.
Five years of either drug
People who stop these drugs often regain the weight, so the bill to plan for runs years, not months. At today's prices, here is one year and five years on each route.
| Route | One year | Five years |
|---|---|---|
| Wegovy pen at NovoCare, 0.25 mg to 2.4 mg | $4,188 | $20,940 |
| Wegovy HD pen at NovoCare, 7.2 mg | $4,788 | $23,940 |
| Zepbound at LillyDirect, 5 mg | $4,788 | $23,940 |
| Zepbound at LillyDirect, 7.5 mg to 15 mg with a refill inside 45 days | $5,388 | $26,940 |
| Zepbound at LillyDirect, 10 mg to 15 mg without that refill | $8,388 | $41,940 |
| Wegovy pen paid from an HSA, 22 percent tax bracket | $3,267 | $16,335 |
| Wegovy with insurance that covers it and the savings card at its lowest copay | $300 | $1,500 |
Each figure is the monthly price checked November 16, 2026, times 12 or 60. The HSA row takes 22 percent federal tax off the Wegovy pen. Zepbound's savings card ends December 31, 2026, so it has no five-year row. Prices will change over five years.
Questions people ask
Is Wegovy cheaper than Zepbound?
Which works better, Wegovy or Zepbound?
Are Wegovy and Zepbound the same drug?
Is there a savings card for Wegovy and Zepbound?
Does Medicare cover Wegovy or Zepbound?
Compare other GLP-1 medications
- Ozempic vs Wegovy
- Ozempic vs Mounjaro
- Zepbound vs Ozempic
- Foundayo vs the Wegovy pill
- Tirzepatide vs semaglutide
- Mounjaro vs Zepbound
- Wegovy vs Mounjaro
- Is there a generic GLP-1?
- Every GLP-1 medication side by side
- Wegovy cost and Zepbound cost
Sources
Evidence checked November 15, 2026
Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.
7 documents
- What Wegovy is approved for and its dosesFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
- What Zepbound is approved for and its dosesFDA prescribing information for Zepbound (DailyMed, revised August 2026)
- SURMOUNT-5: tirzepatide against semaglutide in 751 adults with obesity and no type 2 diabetes, 20.2 percent against 13.7 percent of body weight at 72 weeksAronne LJ et al. N Engl J Med 2025;393(1):26-36 (PubMed 40353578)
- Zepbound's list price range for one fill, before insurance or discountsZepbound cost information (Eli Lilly)
- Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
- The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)
- Wegovy's $274 Medicare negotiated price for a 30-day supply from January 1, 2027CMS fact sheet on 2027 negotiated prices
Prices from NovoCare, LillyDirect and the makers' savings card and list price pages, checked November 16. How we check prices.